ORIC Pharmaceuticals, Inc.

DB:4TZ Stock Report

Market Cap: €644.8m

ORIC Pharmaceuticals Management

Management criteria checks 3/4

ORIC Pharmaceuticals' CEO is Jacob Chacko, appointed in May 2018, has a tenure of 6.5 years. total yearly compensation is $3.15M, comprised of 18.9% salary and 81.1% bonuses, including company stock and options. directly owns 1.03% of the company’s shares, worth €6.66M. The average tenure of the management team and the board of directors is 5.3 years and 4.6 years respectively.

Key information

Jacob Chacko

Chief executive officer

US$3.2m

Total compensation

CEO salary percentage18.9%
CEO tenure6.5yrs
CEO ownership1.0%
Management average tenure5.3yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jacob Chacko's remuneration changed compared to ORIC Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$120m

Jun 30 2024n/an/a

-US$111m

Mar 31 2024n/an/a

-US$102m

Dec 31 2023US$3mUS$596k

-US$101m

Sep 30 2023n/an/a

-US$93m

Jun 30 2023n/an/a

-US$93m

Mar 31 2023n/an/a

-US$90m

Dec 31 2022US$4mUS$572k

-US$89m

Sep 30 2022n/an/a

-US$91m

Jun 30 2022n/an/a

-US$85m

Mar 31 2022n/an/a

-US$85m

Dec 31 2021US$7mUS$536k

-US$79m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$91m

Mar 31 2021n/an/a

-US$81m

Dec 31 2020US$6mUS$489k

-US$74m

Sep 30 2020n/an/a

-US$54m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$30m

Dec 31 2019US$672kUS$456k

-US$27m

Dec 31 2018US$2mUS$290k

-US$21m

Compensation vs Market: Jacob's total compensation ($USD3.15M) is above average for companies of similar size in the German market ($USD1.46M).

Compensation vs Earnings: Jacob's compensation has been consistent with company performance over the past year.

CEO

Jacob Chacko (45 yo)

6.5yrs

Tenure

US$3,153,083

Compensation

Dr. Jacob M. Chacko, M.D., MBA, has been Chief Executive Officer and Director of ORIC Pharmaceuticals, Inc. since May 2018 and has been its President since May 2019. Dr. Chacko joined the ORIC Pharmaceutic...

Leadership Team

NamePositionTenureCompensationOwnership
Richard Heyman
Co-Founder9.7yrsUS$186.87k0.32%
€ 2.1m
Jacob Chacko
President6.5yrsUS$3.15m1.03%
€ 6.7m
Dominic Piscitelli
Chief Financial Officer5.2yrsUS$1.45m0.12%
€ 765.8k
Pratik Multani
Chief Medical Officer6.2yrsUS$1.51m0.034%
€ 217.6k
Charles Sawyers
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Scott Lowe
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Lori Friedman
Chief Scientific Officer5.3yrsno datano data
Christian Kuhlen
General Counsel4.6yrsno datano data
Daniel Iazzetti
VP & Head of People2.2yrsno datano data
Edna Chow Maneval
Senior Vice President of Clinical Development5.7yrsno datano data
Matthew Panuwat
Chief Business Officer6yrsno datano data
Keith Lui
Senior VP of Commercial & Medical Affairsless than a yearno datano data

5.3yrs

Average Tenure

57yo

Average Age

Experienced Management: 4TZ's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Richard Heyman
Co-Founder9.7yrsUS$186.87k0.32%
€ 2.1m
Jacob Chacko
President6.5yrsUS$3.15m1.03%
€ 6.7m
Charles Sawyers
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Scott Lowe
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Laurence Lasky
Member of Scientific Advisory Boardno datano datano data
Angie You
Independent Director3yrsUS$140.37k0%
€ 0
Lori Kunkel
Independent Director4.4yrsUS$133.87k0.029%
€ 187.3k
Mardi Dier
Independent Director4.8yrsUS$147.87k0%
€ 0
Steven Hoerter
Independent Director3.3yrsUS$141.37k0%
€ 0

4.6yrs

Average Tenure

62.5yo

Average Age

Experienced Board: 4TZ's board of directors are considered experienced (4.6 years average tenure).